Pharmacists in Park Forest, IL Accepting Medicare

3 Pharmacists found. Showing 1 - 3

Sybil Webb, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15 S Orchard Dr, Park Forest, IL 60466 Phone: 708-481-7878    Fax: 708-481-3732

Dr. Dominika Kusper Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Main St, Park Forest, IL 60466 Phone: 708-747-5562

Ms. Susan Marie Desanto, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15 S Orchard Dr, Park Forest, IL 60466 Phone: 708-481-7878    Fax: 708-481-3732

News Archive

Reducing levels of protein FKBP51 may yield new antidepressant therapies

Decreasing expression of a protein associated with susceptibility to depression made old mice resistant to depressive-like behavior while improving their hormonal response to stress, a study led by researchers at the University of South Florida found. The lack of this protein, FKBP51, did not adversely affect their memory, learning, or basic motor functions.

Analyzing how well the individual mandate may work

Politico looks at the practical task ahead for the health law's individual mandate.

Probiotics shows promise in reducing both incidence and severity of necrotizing enterocolitis

"Good" bacteria that live in our intestines have been linked with a variety of health benefits, from fighting disease to preventing obesity. In a new study, Kriston Ganguli of Massachusetts General Hospital for Children and Harvard Medical School and her colleagues have discovered another advantage to these friendly microscopic tenants: Chemicals secreted by good bacteria that typically live in the intestines of babies could reduce the frequency and severity of a common and often-lethal disease of premature infants.

Study shows kids who overestimate their popularity display less aggression

Children who overestimate their popularity are less likely to be bullies than those who underestimate or hold more accurate assessments of their social standing, finds new research to be presented at the 108th Annual Meeting of the American Sociological Association.

Researchers evaluate new drug for spinal muscular atrophy in a broader spectrum of patients

The rarity of spinal muscular atrophy (SMA) means that promising new treatments may be tested in only a limited spectrum of patients before approval. Investigators evaluated a newly approved drug, onasemnogene abeparvovec, in a broader spectrum of patients in order to obtain expanded data on its side effects profile.

Read more Medical News

› Verified 2 days ago